Same-patient prospective comparison of botox versus dysport for the treatment of primary axillary hyperhidrosis and review of literature

Journal of Drugs in Dermatology

Volumn 10, Issue 9, 2011, Pages 1013-1015

  Vergilis Kalner, Irene J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; AXILLA; AXILLARY HYPERHIDROSIS; CASE REPORT; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; HYPERHIDROSIS; INJECTION SITE PAIN; MEDICAL LITERATURE; PATIENT SATISFACTION; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; SWEATING; TOPICAL TREATMENT; TREATMENT OUTCOME;

AXILLA; BOTULINUM TOXINS, TYPE A; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERHIDROSIS; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TIME FACTORS; YOUNG ADULT;

EID: 80053300209     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Durand A, Serment G. Botulism toxin in practice. Ann Readapt Med Phys. 2003;46(6):386-388. (Pubitemid 37039799)
2. Glaser DA. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulium toxin type A. J Drugs Dermatol. 2004;3(6):627-631.
3. Lowe NJ, Campanati A, et al. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol. 2004;151(6):1115-1122. (Pubitemid 40030157)
4. Bhidayasiri R, Truong DD. Evidence for effectiveness of botulinum toxin for hyperhidrosis. J Neural Transm. 2008;115:641-645. (Pubitemid 351534035)
5. Schnider P, Moraru E, et al. Botulinum toxin in the treatment of focal hyperhidrosis. Wein Klin Wochenschr. 2001;113(suppl 4):36-41. (Pubitemid 33015391)
6. Botox approved for severe underarm sweating. FDA Consum. 2004;38(5):3.
7. Absar MS, Onwudike M. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis. Dermatol Surg. 2008;34(6):751-755. (Pubitemid 351792285)
8. Talarico-Filho S, Mendonca do Nascimento M, et al. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis. Dermatol Surg. 2007;33(1):44S-50S.
9. Marti N, Ramon D, et al. Botulinum toxin type A for treatment of primary hyperhidrosis: A perspective study of 52 patients. Actas Dermosifiliogr. 2010;101(7):614-621.
10. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: Randomized, parallel group, double blind, placebo controlled trial. BMJ. 2001;323:596-599. (Pubitemid 32846124)
11. Naumann M, Lowe NJ, et al. Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: A prospective study. Arch Dermatol. 2003;139:731-736. (Pubitemid 36705939)
12. Naumann MK, Hamm H, Lowe NJ. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: A randomized controlled trial. Br J Dermatol. 2002;147:1218-1226. (Pubitemid 36963031)
13. Odderson IR. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis. Dermatol Surg. 2002;28:480-483. (Pubitemid 34686631)
14. Lowe NJ, Glaser DA, et al. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol. 2007;56(4):604-611. (Pubitemid 46400197)
15. Galadari I, Alkaabi J. Botulinum toxins in the treatment of axillary hyperhidrosis. Skinmed. 2003;2(4):209-211.
16. Bechara FG, Sand M, et al. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: A perspective, randomized, controlled study. Ann Plast Surg. 2007;58(3):299-302. (Pubitemid 46667877)